The dollar’s decline is yet another positive for the broad market — including AI stocks
A softer dollar is a boon for the S&P 500 because a large number of companies in the index generate meaningful sales overseas.
Pfizer says no major tornado damage to drug manufacturing areas of North Carolina facility
The pharmaceutical company did not say whether it expected the tornado damage to lead to new drug shortages for sterile injectables.
Sanofi expects infant RSV shot to roll out before respiratory virus season this fall
Sanofi said it is working with a CDC panel to include Beyfortus on the childhood immunization schedule and the Vaccines for Children Program.
Kenvue CEO says consumers are spending on brand-name health products even as they pull back in other areas
Thibaut Mongon’s remarks follow Kenvue’s second-quarter earnings beat, which was fueled by resilient demand for brands like Band-Aid, Tylenol and Aveeno.
Wall Street rides high into next week as traders brace for a major Fed decision and key earnings
Traders are coming up against a big Federal Reserve meeting and the biggest week of earnings season.
Former Trump lawyer Michael Cohen settles legal fees suit with Trump Organization
Michael Cohen sued Donald Trump’s company for legal fees related to congressional testimony. He is a key witness against Trump in his New York criminal case.
JPMorgan says this little-known biotech company could rally 66%
The firm initiated coverage on Travere Therapeutics with an overweight rating and price target of $26, citing long-term growth potential.
Another interest rate hike is likely coming from the Federal Reserve. Here are 5 ways it could affect you
The U.S. central bank has indicated another increase in interest rates is coming as it tries to further ease inflation.
The weakening dollar could mean good news for emerging markets. How to play it
With the dollar beginning to fall as the Fed nears the end of its rate hike cycle, emerging market equities look set to benefit.
Astranis internet satellite malfunctions before beginning Alaska service, backup planned for spring
Astranis suffered a malfunction with its first commercial satellite in orbit – but has a backup satellite it plans to bring into service by this spring.
